Abstract
Item-Level Analysis of Clinical Measures in Patients With Early Symptomatic Alzheimer’s Disease Following Treatment With High-Dose Aducanumab in the Phase 3 EMERGE Study (P1-1.Virtual)
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have